-
Uncategorized3 months agoGlobal collaboration aims to create safer cancer therapeutics
An international collaboration is set to evaluate chemotherapeutic toxicity in human organoids, aiming to generate safer and more effective cancer therapeutics. iXCells Biotechnologies, a provider of...
-
Uncategorized3 months agoDDW Highlights: 26 March 2026
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates the key stories of the previous week to keep...
-
Uncategorized3 months agoObesity could be treated without suppressing appetite
Obesity could be treated in other ways than using drugs suppressing appetite, a study reveals. Researchers identified how brown fat cells, which are linked to weight loss, communicate...
-
Uncategorized3 months agoWhitepaper: Secure your place in the IND race
A new exclusive whitepaper is now available from Lonza entitled ‘Secure your place in the IND race with a rapid tox approach‘. Early tox material can...
-
Uncategorized3 months agoJust – Evotec Biologics enters $10m agreement with BARDA
Evotec’s subsidiary and CDMO, Just – Evotec Biologics, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to...
-
Uncategorized3 months agoNew protein drugs could pave way for faster drug development
A new class of protein drugs have shown amenability to multiple isotopes, paving the way for faster radiopharmaceutical drug development. Biotechnology company Molecular Partners announced preclinical...
-
Uncategorized3 months agoGilead to advance first T cell engager for autoimmune diseases
Gilead Sciences has entered an agreement to acquire Ouro Medicines, a biotechnology company focused on developing T cell engager therapies for autoimmune diseases. The acquisition adds...
-
Uncategorized3 months ago‘Supercharged’ T cells could improve prostate cancer treatment
Scientists have engineered new ‘supercharged’ immune cells that could attack prostate cancer more effectively. Researchers at UCLA and Stanford Medicine researchers, in collaboration with scientists from the...
-
Uncategorized3 months agoTwelve startups to showcase at SLAS Europe 2026
SLAS, the Society of Laboratory Automation and Screening, has introduced the 12 companies selected for the Innovation AveNEW programme at SLAS Europe 2026 Conference and Exhibition,...
-
Uncategorized3 months agoLilly’s triple agonist significantly reduces A1C and weight
Eli Lilly has announced positive topline results from TRANSCEND-T2D-1, a Phase III clinical trial evaluating the efficacy and safety of retatrutide, an investigational first-in-class GIP, GLP-1...
An obesity drug deep-dive, and peptides move mainstream
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
